Topics

Q BioMed, Jubilant Radiopharma Enter Commercial Pact

05:14 EDT 3 Oct 2019 | Contract Pharma

Once approved, Q BioMed to serve as contract manufacturer of non-opioid cancer palliation drug, Strontium-89 Chloride Injection, in the U.S.

Original Article: Q BioMed, Jubilant Radiopharma Enter Commercial Pact

NEXT ARTICLE

More From BioPortfolio on "Q BioMed, Jubilant Radiopharma Enter Commercial Pact"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...